Active ingredients: cefotaxime
What it is used for
INDICATIONS: Cefotaxime is indicated for the treatment of the following types of injection when caused by susceptible micro-organisms: Infections of the respiratory tract (upper and lower). Infections of the urinary tract. Septicaemia - concomitant therapy with an aminoglycoside may be instituted prior to isolation of the causative organism. Intra-abdominal infection. Gonorrhoea (including gonorrhoea caused by beta lactamase producing strains of N. gonorrhoeae). Ear, nose and throat infections. Skin and skin structure infections. Bone and joint infections. Meningitis - cefotaxime should be combined with an appropriate alternative antibiotic (ampicillin, chloramphenicol or pencillin G) for initial therapy in children, (excluding neonates) pending the availability of culture and sensitivity results. In adults, the empirical use of cefotaxime should be restricted to patients suspected of having meningitis caused by Gram negative enteric bacilli. Cefotaxime may be used for the prevention of post-operative infection in obstetrical surgery, vaginal and abdominal hysterectomy and biliary surgery. In serious cases, cefotaxime may be used, if considered appropriate,before the results of sensitivity tests become available. The emergency of resistance to cefotaxime may complicate treatment.
How to take it
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
- Store below 25 degrees Celsius
- Protect from Light
- Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Clear glass vial containing a white to pale yellow crystalline powder.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on February 1, 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy?
For the active ingredient cefotaxime
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems